BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

741 related articles for article (PubMed ID: 30849352)

  • 1. Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis.
    Gibbs J; Mei S; Economos K; Lee YC; Kanis MJ
    Am J Obstet Gynecol; 2019 Jul; 221(1):53.e1-53.e6. PubMed ID: 30849352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina.
    Kosary CL
    Semin Surg Oncol; 1994; 10(1):31-46. PubMed ID: 8115784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Medicaid expansion on women with gynecologic cancer: a difference-in-difference analysis.
    Albright BB; Nasioudis D; Craig S; Moss HA; Latif NA; Ko EM; Haggerty AF
    Am J Obstet Gynecol; 2021 Feb; 224(2):195.e1-195.e17. PubMed ID: 32777264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgery Versus Radiation Treatment for High-Grade Neuroendocrine Cancer of Uterine Cervix: A Surveillance Epidemiology and End Results Database Analysis.
    Hou WH; Schultheiss TE; Wong JY; Wakabayashi MT; Chen YJ
    Int J Gynecol Cancer; 2018 Jan; 28(1):188-193. PubMed ID: 29206662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of the impact of pathology review in gynecologic cancer.
    Chafe S; Honore L; Pearcey R; Capstick V
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1433-8. PubMed ID: 11121644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes.
    Gardner AB; Charo LM; Mann AK; Kapp DS; Eskander RN; Chan JK
    Clin Exp Metastasis; 2020 Feb; 37(1):107-113. PubMed ID: 31758289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical analysis of brain metastasis in gynecologic cancer: a retrospective multi-institute analysis.
    Kim YZ; Kwon JH; Lim S
    J Korean Med Sci; 2015 Jan; 30(1):66-73. PubMed ID: 25552885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gynecologic cancers: factors affecting survival after pulmonary metastasectomy.
    Clavero JM; Deschamps C; Cassivi SD; Allen MS; Nichols FC; Barrette BA; Larson DR; Pairolero PC
    Ann Thorac Surg; 2006 Jun; 81(6):2004-7. PubMed ID: 16731120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic characteristics, oncologic outcomes, and prognostic factors in neuroendocrine cervical carcinoma: a Neuroendocrine Cervical Tumor Registry study.
    Salvo G; Flores Legarreta A; Ramalingam P; Jhingran A; Bhosale P; Saab R; Gonzales NR; Chisholm GB; Frumovitz M
    Int J Gynecol Cancer; 2023 Sep; 33(9):1359-1369. PubMed ID: 37567596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of malignant tumors in gynecology].
    Ledermair O; Michlmayr G; Hammer J
    Wien Med Wochenschr; 1986 Jun; 136(11-12):307-11. PubMed ID: 3751078
    [No Abstract]   [Full Text] [Related]  

  • 11. Bone metastasis from gynecologic carcinomas: a clinicopathologic study.
    Abdul-Karim FW; Kida M; Wentz WB; Carter JR; Sorensen K; Macfee M; Zika J; Makley JT
    Gynecol Oncol; 1990 Nov; 39(2):108-14. PubMed ID: 2227582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical staging of gynecologic malignancies.
    Averette HE; Donato DM; Lovecchio JL; Sevin BU
    Cancer; 1987 Oct; 60(8 Suppl):2010-20. PubMed ID: 3308062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in the survival of patients diagnosed with cancer in female genital organs in the Nordic countries 1964-2003 followed up to the end of 2006.
    Klint A; Tryggvadóttir L; Bray F; Gislum M; Hakulinen T; Storm HH; Engholm G
    Acta Oncol; 2010 Jun; 49(5):632-43. PubMed ID: 20307243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients.
    Zuna RE; Behrens A
    J Natl Cancer Inst; 1996 Jul; 88(14):980-7. PubMed ID: 8667429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine tumors of the genital tract.
    Eichhorn JH; Young RH
    Am J Clin Pathol; 2001 Jun; 115 Suppl():S94-112. PubMed ID: 11993694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical comparison between neuroendocrine and endometrioid type carcinoma of the uterine corpus.
    Mei S; Gibbs J; Economos K; Lee YC; Kanis MJ
    J Gynecol Oncol; 2019 Jul; 30(4):e58. PubMed ID: 31074241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology.
    Benedet JL; Bender H; Jones H; Ngan HY; Pecorelli S
    Int J Gynaecol Obstet; 2000 Aug; 70(2):209-62. PubMed ID: 11041682
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic value of peritoneal washing cytology in gynecologic malignancies: a controversial issue.
    Binesh F; Akhavan A; Behniafard N; Zabihi S; Hosseinizadeh E
    Asian Pac J Cancer Prev; 2014; 15(21):9405-10. PubMed ID: 25422232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Grading of gynecological tumors : Current aspects].
    Horn LC; Mayr D; Brambs CE; Einenkel J; Sändig I; Schierle K
    Pathologe; 2016 Jul; 37(4):337-51. PubMed ID: 27379622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical analysis of 23 gynecologic carcinoma patients with brain metastasis].
    Zhang JX; Wang SZ; Li B; Zhang ZY
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(23):1843-6. PubMed ID: 27356795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.